Neuron loss in APP transgenic mice

Calhoun, Michael E., Wiederhold, Karl-Heinz, Abramowski, Dorothee, Phinney, Amie L., Probst, Alphonse, Sturchler-Pierrat, Christine, Staufenbiel, Matthias, Sommer, Bernd +1 more·1998·Nature
DOI 10.1038/27351

Cited by (501)

Items 401–500 of 501

  1. Alzheimer's disease: Mechanisms and development of therapeutic strategies
    Takeshi Tabira · 2003 · Geriatrics and gerontology international/Geriatrics & gerontology international
  2. The Value of the Object Recognition Paradigm in Investigating Animal Models of Alzheimer's Disease
    Chantal Mathis · 2018 · Handbook of behavioral neuroscience
  3. Alzheimer's Disease: Clinical Features, Neuropathologies and Biochemical Abnormalities, Genetics, Models, and Experimental Therapeutics
    Donald L. Price, David Borchelt, Philip C. Wong · 2005 · Elsevier eBooks
  4. APP-Based Transgenic Models: The APP23 Model
    Debby Van Dam, Peter Paul De Deyn · 2010 · Neuromethods
  5. Demenz
    Sebastian Knell, Dietmar Rudolf Thal, Volker Lipp · 2022 · Verlag Karl Alber eBooks
  6. Cognitive Impairment in Transgenic Aβ and Tau Models of Alzheimer’s Disease
    Karen H. Ashe · 2007 · Springer eBooks
  7. Schon gegen Alzheimer geimpft? - Mechanismen zerebraler Amyloidosen
    DT Winkler, Mathias Jucker · 2001 · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
  8. Animal Models of Alzheimer's Disease
    Prashant Bharadwaj · 2019 · Wiley eBooks
  9. Learning Mutants
    Louis D. Matzel · 2002
  10. Animal Models of Alzheimer’s Disease
    Tomomi Kiyota · 2013 · Springer protocols handbooks/Springer protocols
  11. Neurodegenerative Diseases and Dementia
    Christopher Janus, Hans Welzl · 2016 · Springer eBooks
  12. Behavioural Phenotyping to Study Cognitive and Non-cognitive Symptoms in the Rodent Model of Alzheimer’s Disease
    Apoorva Bettagere Shivakumar, Sonam Fathima Mehak, Sparsha Kumari, Vikyath Saraf, Gireesh Gangadharan · 2022 · Springer eBooks
  13. Early Intraneuronal β-Amyloid Pathology: Do Transgenic Mice Represent Valid Model Systems?
    Oliver Wirths, Thomas A. Bayer · 2008 · The Open Aging Journal
  14. S14 TRANSGENIC MICE MODELS FOR ALZHEIMER??S DISEASE
    Fred VAN LEUVEN · 2006 · Behavioural Pharmacology
  15. Alzheimer disease models and human neuropathology: similarities and diVerences
    Charles J. Duyckaerts, Marie‐Claude Potier, Benoı̂t Delatour · 2008
  16. Alzheimer's Disease
    Richard P Mayeux, Sam Gandy · 2000 · Elsevier eBooks
  17. Contributions of the Glial Injury Response to the Multifactorial Pathogenesis of Alzheimer’s Disease
    Lennart Mucke, Manuel Buttini, Robert W. Mahley, Robert E. Pitas, Jacob Raber, Tony Wyss‐Coray · 2000 · Research and perspectives in neurosciences
  18. Spearmint extract Neumentix downregulates amyloid-β accumulation by promoting phagocytosis in APP23 mice
    Xinran Hu, Ryuta Morihara, Yusuke Fukui, Yuting Bian, Hongming Sun, Ricardo Satoshi Ota-Elliott, Hiroyuki Ishiura, Koji Abe, Toru Yamashita · 2025 · Brain Research
  19. P2-062 Induction of brain-derived neurotrophic factor (BDNF) in plaque-associated glial cells of aged APP23 transgenic mice
    Guido J. Burbach, Rainer Hellweg, Carola A. Haas, Domenico Del Turco, Uwe Deicke, Dorothée Abramowski, Mathias Jucker, Matthias Staufenbiel, Thomas Deller · 2004 · Neurobiology of Aging
  20. Neurodegenerative disorders
    Susanna Pietropaolo, Frans Sluyter, Wim E. Crusio · 2014 · Cambridge University Press eBooks
  21. Pathological Validation of Animal Models of Dementia
    Daniel Nicolae Pirici, Christine Van Broeckhoven, Samir Kumar‐Singh · 2010 · Neuromethods
  22. The Value of Transgenic Models for the Study of Neurodegenerative Diseases
    Donald L. Price, P. C. Wong, Alicja L. Markowska, Gopal Thinakaran, Michael K. Lee, Lee J. Martin, Jeffrey D. Rothstein, Sangram S. Sisodia, David Borchelt · 2001 · Research and perspectives in Alzheimer's disease
  23. Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
    Lars Matthias Ittner, Wei S. Lee, Kristie Stefanoska, Prita Riana Asih, Yazi Diana Ke · 2018 · Springer eBooks
  24. Lipid-based Nanomedicine for Alzheimer's Disease: A Comprehensive Review of Recent Advances
    Sanchit Dhankhar, Nitika Garg, Himanshu Sharma, Samrat Chauhan, Monika Saini · 2024 · Pharmaceutical Nanotechnology
  25. Apoptosis in Neurodegenerative Diseases
    Qiuli Liang, Jianhua Zhang · 2009 · Humana Press eBooks
  26. Mouse Models of Alzheimer’s Disease
    Dwight C. German · 2006 · Springer eBooks
  27. NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE
    Parichehr Pasbakhsh, M. Mehdizadeh, Negar Omidi · 2005
  28. The Role of α-Synuclein in Parkinson’s Disease: A Biophysical Analogy to Aβ and Alzheimer’s Disease
    Peter T. Lansbury · 2000 · Research and perspectives in Alzheimer's disease
  29. 3 Neuropathology of Aging
    Dara L. Dickstein, John H. Morrison, Patrick R. Hof · 2009 · Oxford University Press eBooks
  30. I. Demenz: Medizinische Aspekte
    Sebastian Knell, Dietmar Rudolf Thal, Volker Lipp · 2022 · Verlag Karl Alber eBooks
  31. AD‐Type Neuron Loss in Transgenic Mouse Models
    Kebreten F. Manaye, Peter R. Mouton · 2013 · Wiley eBooks
  32. Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer’s Disease: Parallels with Human AD Evaluation
    Ralph E. Leighty · 2009 · Digital Commons - University of South Florida (University of South Florida)
  33. Pathogenesis and Mechanism of Cerebral Amyloidosis in APP Transgenic Mice
    Mathias Jucker, Michael E. Calhoun, Amie L. Phinney, M. Stalder, Luca Bondolfi, David T. Winkler, Martin C. Herzig, M. Pfeifer, Sonia Boncristiano, Markus Tolnay et al. · 2001 · Research and perspectives in Alzheimer's disease
  34. Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
    James Clement Vickers · 2001 · Elsevier eBooks
  35. Transgenic Technologies and their Application to the Study of Senile Dementia
    Stefan Kolata, Louis D. Matzel · 2010 · Elsevier eBooks
  36. The Amyloid Hypothesis of Cognitive Dysfunction
    David Morgan, Marcia N. Gordon · 2003 · Humana Press eBooks
  37. CCR2 antagonism identifies blood-borne monocytes as a target for prevention of cognitive deficits after seizures
    Soheila Pourkhodadad, Wenyi Wang, Raymond J Dingledine, Nicholas H. Varvel · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins
    Berislav V. Zloković, Jorge A. Ghiso, Blas Frangione · 2000 · Springer eBooks
  39. Targeting Early Stages of Alzheimer’s Disease in a Transgenic Model
    Anna Lord · 2009 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  40. Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
    Janet van Eersel, Fabien Delerue, Lars Matthias Ittner, Yazi Diana Ke · 2014 · Springer eBooks
  41. Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease
    Sam Gandy · 2002 · Handbook of experimental pharmacology
  42. Die Amyloidablagerung in einem Mausmodell der Alzheimer Demenz und die Modulation der β-Amyloid-Peptidentstehung durch membranverankerte Inhibitoren
    Heinke Schieb · 2011 · DuEPublico (University of Duisburg-Essen)
  43. Recombinant AAV gene therapy and delivery for Alzheimer's disease
    Nikisha Carty · 2009
  44. The 5XFAD mouse model: a tool for genetic modulation of Alzheime's disease pathology
    Sadim Jawhar · 2012
  45. Effects of A-beta immunotherapy and Omega-3 fatty acid administration in Alzheimer's transgenic mice
    Maren Jensen · 2006
  46. Neurodegeneration and neurogenesis in mouse models of aging and Alzheimer's disease
    Luca Bondolfi · 2003 · edoc (University of Basel)
  47. Amyloid precursor protein with the Alzheimer´s disease 670/671 mutation : Animal and cellular models
    Ewa Kloskowska · 2008 · Figshare
  48. An assessment of cognitive and sensorimotor deficits associated with appsw and p301l mouse models of alzheimer's disease
    Marcos F Garcia · 2003 · Digital Commons - University of South Florida (University of South Florida)
  49. Neural stem cell biology and neurogenesis in mouse models of aging and Alzheimer's disease
    Florian Ermini · 2006 · edoc (University of Basel)
  50. Stimulating Neuroprotective and Regenerative Mechanisms in Alzheimer Disease
    Anna M. Lilja · 2013 · Zenodo (CERN European Organization for Nuclear Research)
  51. Flavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology
    Kavon P. Rezai-Zadeh · 2008 · Digital Commons - University of South Florida (University of South Florida)
  52. Effects of long-term administration of caffeine in a mouse model for Alzheimer's disease
    William S. Schleif · 2005 · Digital Commons - University of South Florida (University of South Florida)
  53. Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
    Hoang, T · 2012 · UTAS Research Repository
  54. Amyloid β-Peptide and Central Cholinergic Neurons: Involvement in Normal Brain Function and Alzheimer’s Disease Pathology
    Satyabrata Karn, Zhiyun Wei, David MacTavish, Doreen Kabogo, Mee-Sook Song, Jack H. Jhamandas · 2006 · Springer eBooks
  55. Functional Genomics of the Down Syndrome
    Dean Nietiæ · 2001
  56. The effect of dietary omega-3 polyunsaturated fattyacids and curcumin on cognition and pathology in amouse model of amyloid pathology
    Katie Hall · 2011 · ORCA Online Research @Cardiff (Cardiff University)
  57. Quetiapine modulates anxiety-like behaviours and alleviates the decrease of BDNF in the amygdala of an APP/PS1 transgenic mouse model of Alzheimer’s disease
    Adrien Tempier · 2009 · University Library - University of Saskatchewan (University of Saskatchewan)
  58. Archive of SID NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE
    Parichehr Pasbakhsh, Mehdi Mehdizadeh, Negar Omidi · 2005
  59. RetinoicAcidAttenuates-AmyloidDepositionandRescues MemoryDeficitsinanAlzheimer'sDiseaseTransgenic MouseModel
    J. ShawnGoodwin · 2008
  60. Der Einfluss des Geschlechts auf die Neuronenanzahl in einem APP/PS1- doppeltransgenen Mausmodell der Alzheimer-Krankheit
    Abteilung für Neurobiologie · 2006
  61. β-amyloid and Alzheimer disease: recent progress
    Tuo Li, Zhongxin Zhao · 2010 · Academic Journal of Second Military Medical University
  62. Multifaktorielle Genese des Synapsenuntergangs beim Morbus Alzheimer: Eine in vivo 2-Photonen Untersuchung an APP-Knockout und transgenen Alzheimer- Mausmodellen
    Ludwig-Maximilians-Universität München · 2009
  63. DivideandDie:CellCycleEventsasTriggersofNerve CellDeath
    Karl Herrup · 2004
  64. Amyloid- _ and _ in Alzheimer’s Disease
    Akihiko Nunomura, Hyoung‐gon Lee, Xiongwei Zhu, George L. Perry, Rudy J. Castellani, Mark A. Smith · 2005 · Oxidative stress and disease
  65. Model Organisms and Neurogenetics
    David E. Krantz, George R. Jackson · 2007 · Medical psychiatry
  66. In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
    Bernhard Clemens Richard · 2015
  67. Epilepsy in Models of Alzheimer’s Disease
    Heikki Tanila, Asla Pitkänen · 2017 · Elsevier eBooks
  68. Therapiemöglichkeiten der Alzheimer-Krankheit durch passive Immunisierung mit dem NT4X-Antikörper im Tg4-42hom-Mausmodell
    Henning Borgers · 2017
  69. Neuroprotección por 2-(3,4 dihidroxifenil)etanol y ácidos grasos poliinsaturados omega-3 en modelos in vitro e in vivo
    Berta Luzón-Toro · 2006 · Dialnet (Universidad de la Rioja)
  70. Analyse neurodegenerativer Prozesse im Gyrus Dentatus im Tg4-42-Mausmodell der Alzheimerdemenz
    Nils L. Schubert · 2018
  71. DEPLETION OF TDP-43 ACCELERATES NEURODEGENERATION IN AN ALZHEIMER’S MOUSE MODEL, INDEPENDENT OF BETA-AMYLOID PLAQUE BURDEN
    Katherine D. LaClair · 2016
  72. Regulation of apoptosis at the point of cytochrome c in disease models
    Yolanda Y. Huang · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  73. Recombinant AAV Gene Therapy and Delivery
    Nikisha Carty · 2009 · Digital Commons - University of South Florida (University of South Florida)
  74. Beneficial effects of quetiapine in the APP/PS1 transgenic mice: implications for early intervention for Alzheimer's disease
    Shenghua Zhu · 2011 · Mspace (University of Manitoba)
  75. Molecular aspects of metallothioneins in dementias
    Gemma Comes, Anna Escrig, Yasmina Manso, Olaya Fernández‐Gayol, Paula Sanchís, Amalia Molinero, Mercedes Giralt, Javier Carrasco, Juan Hidalgo · 2020 · Elsevier eBooks
  76. Focal glial detection coincides with precedes amyloid plague formation in APPPS1 transgenic mice by PCR
    Talib Fadhil Abbas · 2014 · Iraqi Journal of Science
  77. Estudio de variantes estructurales de ApoA-I y ApoJ recombinantes como aproximación terapéutica en el contexto de la β-amiloidosis cerebral
    Sofía Fernández de Retana · 2018
  78. Endoplasmic Reticulum Stress Contributes To The Decline in Doublecortin Expression in Immature Neurons in Mice with Long-Term Obesity and Memory Impairment
    Kiyomi Nakagawa, Saiful Islam, Masashi Ueda, Toshiyuki Nakagawa · 2021 · Research Square
  79. Cerebral amyloid angiopathy : new insights from transgenic mice
    Martin C. Herzig · 2004 · edoc (University of Basel)
  80. The role of N-truncated Aβ peptides in Alzheimer’s Disease
    José Sócrates López‐Noguerola · 2018
  81. Studies on the Involvement of the Immune system in Alzheimer's disease
    Andrea Marcello · 2010
  82. REFERENCES
    2002 · Elsevier eBooks
  83. New genetic mouse models for neurodegenerative diseases: Contribution of noradrenaline to Alzheimer’s disease pathogenesis and creation of a new genetic model for Parkinson’s disease.
    Ana C. Martinez Hernandez · 2011
  84. Cannabinoid-basierte Therapie in einem Modell für die sporadische Alzheimer-Erkrankung
    Marius E. Sichler · 2022
  85. Nanoskalauntersuchungen vom zellulären Metabolismus mittels Sekundärionen-Massenspektrometrie
    Lena Karsten · 2022
  86. Passive Immunisierung mit dem monoklonalen Antikörper NT4X am Tg4-42-Mausmodell für die sporadische Form der Alzheimer Erkrankung
    Philipp Henniges · 2023
  87. Animal Models of Alzheimer's Disease
    Ammar Y. Jastaniah · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  88. Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies
    Nuraqila Mohd Murshid, Nur Fatin Nabilah Mohd Sahardi, Suzana Makpol · 2024 · International Journal of Molecular Sciences
  89. Long-term antiplatelet therapy protects against cerebral but not parenchymal amyloid plaque formation and neurodegeneration in transgenic mice of Alzheimer’s disease
    Lili Donner, Laura Mara Toska, Marlene Pils, Fabian Rehn, Oliver Bannach, Margitta Elvers · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Impact of N-terminally truncated Aß4-42 on memory and synaptic plasticity - Tg4-42 a new mouse model of Alzheimer's disease
    Katharina Dietrich · 2015
  91. Mouse Models of Inherited Human Neurodegenerative Disease
    Karl Herrup · 2007 · Elsevier eBooks
  92. Impact of A β and Tau on Cognition in Mouse Models of Alzheimer’s Disease
    Maya A. Koike, Kristoffer Myczek, Kim N. Green, Frank M. LaFerla · 2008 · Humana Press eBooks
  93. Modulation of Alzheimer’s Pathology in Transgenic Mouse Models
    Carmen Cecilia Duma · 2009
  94. Mouse models of Alzheimer’s disease pathology
    Sunwoo Kim, Nora E. Gray · 2025 · Elsevier eBooks
  95. Toll-like receptor 9 contributes in microglial activation and lysosomal dysfunction to promote Alzheimer’s disease
    Moïse de Lavergne, Lucie Mazzola, Katrina Podsypanina, Cecilia Estrella, Philippe Verwaerde, Irini Evnouchidou, Guillaume Darrasse-Jèze, Marie‐Claude Potier, Sheela Vyas, Bénédicte Manoury · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Intégrité de la barrière hémato-encéphalique et transport du peptide bêta-amyloïde dans la maladie d'Alzheimer
    Tuan Minh Do · 2012 · theses.fr (ABES)
  97. Développement et évaluation d'agents de contraste pour détecter la maladie d'Alzheimer par IRM : coloration par le Gadolinium et nanocorps ciblant les protéines Aβ et Tau
    Clémence Dudeffant · 2018 · theses.fr (ABES)
  98. Du rôle physiologique de la protéine prion cellulaire à l'infection par les prions : régulation/dérégulation du module de signalisation PDK1/TACE α-secrétase
    Juliette Ezpeleta · 2019
  99. La protéine prion cellulaire : rôles physiologiques et implications croisées dans les maladies neurodégénératives amyloïdes
    Vincent Baudouin · 2020 · theses.fr (ABES)
  100. Amyloid-β Transmissibility
    Claudia A. Duran-Aniotz, Rodrigo Morales, Inés Moreno‐González, Claudio A. Soto · 2013 · Research and perspectives in Alzheimer's disease